An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Pennsylvania House Bill 2747 amends the state's Controlled Substance, Drug, Device and Cosmetic Act to add eight specific synthetic benzimidazole-opioid substances, commonly known as nitazenes, to Schedule I of controlled drugs. These substances are classified as having a high potential for abuse with no currently accepted medical use in the United States. The bill directly affects individuals who manufacture, sell, or possess these specific chemicals by subjecting them to the strict penalties and regulations associated with Schedule I drugs. The new provisions take effect 60 days after the act is signed into law.